Shares of R1 RCM RCM were unchanged after the company reported Q2 results.
Quarterly Results
Earnings per share were up 100.00% over the past year to $0.06, which missed the estimate of $0.07.
Revenue of $353,400,000 higher by 12.30% year over year, which beat the estimate of $343,420,000.
Looking Ahead
R1 RCM sees FY21 sales of $1.46 billion-$1.48 billion.
Details Of The Call
Date: Aug 03, 2021
Time: 08:00 AM
Technicals
Company's 52-week high was at $31.28
52-week low: $13.48
Price action over last quarter: down 12.41%
Company Profile
R1 RCM Inc helps U.S. hospitals, physicians and other healthcare providers to more efficiently manage their revenue cycle operations, which encompass patient registration, insurance, and benefits verification, medical treatment documentation and coding, bill preparation and collections. The company's core offering consists of comprehensive, integrated technology and revenue cycle management services. The majority of the revenue comes from the operating fees received.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.